Amy Tiersten

Academic / Other · 2 registered clinical trials.

Status	Trial	Phase	Started
Completed	Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer HER2-Negative Metastatic Breast Cancer, Recurrent Ovarian Cancer	Phase 1	2018-05-17
Completed	Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of A Breast Cancer	Phase 2	2015-12-16